Researchers analyzed 73 decision aids for breast, cervical, colon and prostate cancers. Less than half had been promoted for use with subsequent screening behavior, and only 18 were found to be used for shared decision making.
“Our goal was to determine whether decision aids could potentially lead to better shared decision-making regarding screening between the patient and the clinician. There is evidence that decision aids are fairly effective in improving patient knowledge but we found that they may not be used as well and effectively as they could be,” said lead author Masahito Jimbo, MD, PhD, associate professor in family medicine and urology at the University of Michigan Medical School in a news release.
More Articles on Oncology Quality:
Study: Medication Error Rate Among Pediatric Cancer Patients Higher at Home Than in Hospital
The Oncology Service Line in the Coming Year: 4 Developments
FDA Issues Warning on Potential Breast Cancer Drug Mix-Up
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
